Prestige Consumer Healthcare Inc. (PBH)

Market Cap	2.89B
Revenue (ttm)	1.11B
Net Income (ttm)	200.84M
Shares Out	48.08M
EPS (ttm)	4.04
PE Ratio	14.85
Forward PE	12.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	424,684
Open	60.23
Previous Close	59.99
Day's Range	58.50 - 60.24
52-Week Range	58.50 - 90.04
Beta	0.39
Analysts	Buy
Price Target	86.40 (+43.98%)
Earnings Date	Nov 6, 2025

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Feb 10, 2005
• Employees: 600
• Stock Exchange: NYSE
• Ticker Symbol: PBH
• Website: https://www.prestigebrands.com

Financial Performance

In 2024, PBH's revenue was $1.14 billion, an increase of 1.10% compared to the previous year's $1.13 billion. Earnings were $214.61 million, an increase of 2.52%.

Analyst Summary

According to 5 analysts, the average rating for PBH stock is "Buy." The 12-month stock price target is $86.4, which is an increase of 43.98% from the latest price.

Price Target

$86.4

(43.98% upside)

Analyst Consensus: Buy